Revolutionize Discovery
with Human
3D Disease Models
Generate more human-like responses with more human-like tissues using VivoSphere™ tissue engineering solutions.
VivoSphere™ provides 3D cell culture models for in vitro drug discovery and toxicity testing using tissue engineering technologies.
3D Cell Culture
More physiologically relevant condition for cell culture.
Oncology
Replicate 3D tumor microenvironment with control over extracellular matrix components and mechanical properties.
HTS screening
Assay-ready 3D tissues compatible with lab automation system.
VivoSphere™ Tissue-Engineered Model
Encapsulate key features of human biology in our 3D models to provide more translatable results for drug discovery.
- High inter- and intra-batch uniformity
- Tunable tissue microenvironment with hydrogel
- Support a wide range of cell types, including non-aggregating cells
- Encapsulate high number of cells for better assay readout
- Assay-ready for high-throughput screening
What’s New?
- Dr. Elizabeth Lipke, co-founder of VivoSphere, inducted into the American Institue for Medical and Biological Engineering (AIMBE) College of Fellows.
- VivoSphere featured in a feature article by Auburn University New Venture Accelerator.
- Winner of 2023 Alabama Launchpad Concept Stage.
- Finalist of 2023 Alabama Launchpad.
- Startup Showcase at 2023 Gener8tor Healthcare Conference.
- 2022 BioAlabama Annual Conference.
- Awardee of the 2021 NSF I-Corps Grant for customer discovery.
- Winner of 2019 LAUNCH Innovation Grant from Auburn University.
- VivoSphere team nominated for the 2024 SLAS Ignite Award.
- VivoSphere was selected as the SLAS2024 Innovation AveNEW company. Meet us at SLAS2024 International Conference & Exhibition, Feb 3-7, Boston, MA.
- VivoSphere team won 2023 Alabama Launchpad Concept Stage.
- Our team attended and presented our work at 2023 AACR conference in Orlando, FL.
VivoSphere in publications
- Rapid Production of Cell‐Laden Microspheres Using a Flexible Microfluidic Encapsulation Platform
- Droplet Microfluidics-Based Fabrication of Monodisperse Poly (ethylene glycol)-Fibrinogen Breast Cancer Microspheres for Automated Drug Screening Applications
- Engineered cardiac tissue microsphere production through direct differentiation of hydrogel-encapsulated human pluripotent stem cells
- Encapsulation of Equine Endothelial Colony Forming Cells in Highly Uniform, Injectable Hydrogel Microspheres for Local Cell Delivery
- Microfluidic Production of Cell-Laden Microspheroidal Hydrogels with Different Geometric Shapes
- Cell engraftment, vascularization, and inflammation after treatment of equine distal limb wounds with endothelial colony forming cells encapsulated within hydrogel microspheres
VivoSphere in the news
Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award
New Innovative Approaches to Lab Automation
Contact Us
Have a question, comment, or inquiry for the VivoSphere team? We would love to answer them. Please contact us at [email protected], and a VivoSphere representative will be in touch shortly.
Copyright © 2024 VivoSpheres. All Rights Reserved